Use of amifostine (AMI) to reduce toxicity following Taxol-based chemotherapy in solid tumors. A randomized phase II study of the Hellenic Cooperative Oncology Group

✍ Scribed by Bafaloukos, D.; Samelis, G.; Mela, A.; Aravantinos, G.; Xiros, N.; Dimou, M.; Kalofonos, H.P.; Samantas, E.; Retalis, G.; Papakostas, P.

• Book ID: 122864807
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 178 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(01)81779-2